EU Q&A on Information Obligations Associated with Interruption or Discontinuation of Supply
The article highlights the key points related to the manufacturers’ obligations in case of product supply being interrupted or discontinued.
The article highlights the key points related to the manufacturers’ obligations in case of product supply being interrupted or discontinued.
The article outlines the basics of the regulatory framework for innovative medical devices.
The final article of the cycle clarifies certain specific regulatory matters associated with submissions, such as the applicability of transitional provisions or modifications to submissions and the way they should be introduced.
The new article further describes in detail the specific approach to be followed when making a submission, highlighting the key points to be considered by the parties involved.
The final article of the cycle provides additional clarifications regarding certain specific aspects associated with the use of electronic records in the context of clinical investigations.
The new article provides further clarifications regarding the clinical follow-up and supervision to be conducted by the parties responsible for clinical investigations.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report